TEVA - AbbVie stock slides 6% amid concerns about falling Humira sales April, 26 2024 02:09 PM Teva Pharmaceutical Industries Limited American Depositary Shares 2024-04-26 14:09:10 ET More on AbbVie AbbVie Inc. (ABBV) Q1 2024 Earnings Call Transcript AbbVie's Q1: Positive Surprise AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment AbbVie Q1 report beats Street despite plunging Humira sales AbbVie off 3% despite quarterly beats, 2024 guidance raise For further details see: AbbVie stock slides 6% amid concerns about falling Humira sales